The Latest Cardiac and Vascular News
SHENZHEN, China , Aug. 30, 2023 /PRNewswire/ — LifeTech Scientific Corporation (the “Company” or “Lifetech”), a leading company specialized in minimally invasive interventional medical devices for cardio-cerebrovascular and peripheral vascular diseases, today announced the unaudited consolidated results of the Company and its subsidiaries (collectively the “Group”) for the six months ended 30 June 2023 (the “Reporting […]
AACHEN, Germany–(BUSINESS WIRE)–Protembis GmbH (Protembis) a privately-held emerging cardiovascular medical device company, announced today the appointment of Professor J Mocco MD, MS, FAANS, FAHA of Icahn School of Medicine at Mount Sinai, NY, USA as an independent member of their Board of Directors. “I am delighted to welcome Professor Mocco […]
TEL AVIV, Israel–(BUSINESS WIRE)–Radiaction Medical, LTD (“Radiaction”), a medical device company whose mission is to provide radiation protection to the entire medical staff during interventional procedures, today made two announcements. First, it has raised $12.6 million in Series C2 funding led by U.S. private equity fund InnovaHealth Partners with participation from additional co-investors. […]
PALO ALTO, Calif., Aug. 29, 2023 /PRNewswire/ — Vista.ai, a pioneer in AI-assisted MRI solutions, and HekaBio K.K., a Japan-based healthcare investment, development and commercialization platform, have signed a strategic partnership agreement whereby HekaBio will market Vista.ai’s innovative One Click™ MRI in Japan. Vista.ai’s AI-enhanced One-click Workflow Optimization for Cardiac MRI Cardiac MRI (CMR) […]
NEW YORK, Aug. 28, 2023 (GLOBE NEWSWIRE) — LEXEO Therapeutics (LEXEO), a clinical-stage gene therapy company advancing gene therapy candidates for genetically defined cardiovascular diseases and a genetically defined sub-group of Alzheimer’s disease, today announced a strategic investment from Sarepta Therapeutics, Inc. (Sarepta) to support the advancement of LEXEO’s adeno-associated virus (AAV) […]
RVINE, Calif.–(BUSINESS WIRE)–Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, is pleased to announce that Lucas Buchanan has been appointed to the Endologix Board of Directors. “We are thrilled to welcome Lucas to our Board of Directors” […]
DUBLIN, Aug. 22, 2023 /PRNewswire/ — Medtronic plc (NYSE:MDT) today announced financial results for its first quarter of fiscal year 2024 (FY24), which ended July 28, 2023. Key Highlights Revenue of $7.7 billion increased 4.5% as reported and 6.0% organic GAAP diluted earnings per share (EPS) of $0.59 decreased 16%; non-GAAP diluted EPS of $1.20 increased 6% Company increases […]
LOS GATOS, Calif., Aug. 22, 2023 /PRNewswire/ — Advanced NanoTherapies Inc. (ANT), a clinical-stage medical device company committed to solving the most significant challenges in vascular disease through the creative applications of nanotechnology, today announced a $4M Series A extension from a prominent undisclosed strategic medical device company. Additionally, ANT successfully treated the first cohort of […]
PLEASANTON, Calif., Aug. 21, 2023 /PRNewswire/ — Expanse Medical, the innovative medical device incubator founded by Eitan Konstantino with focus on global innovations, proudly announces the addition of Shlomi Nachman to its Board of Directors and the Board of its spinoff, Expanse ICE. Mr. Nachman’s distinguished career includes his recent tenure as Johnson & Johnson […]
DUBLIN, Aug. 17, 2023 /PRNewswire/ — The board of directors of Medtronic plc (NYSE:MDT) on Thursday, August 17, 2023, approved an increase in the company’s cash dividend for the second quarter of fiscal year 2024 versus the prior year, raising the quarterly amount to $0.69 per ordinary share. This quarterly declaration is consistent with the first […]
